Vymedic
About this raise
Vymedic, with a post-money valuation of $23 million, is raising crowdfunding on NetCapital. The company has manufactured Vymune, a broad-spectrum antiviral, that beats other treatments in the suppression of influenza. Vymune is not strain-specific and activates the immune system against the illness. Cynthia Winning founded Vymedic in March 2020. The current crowdfunding round has a minimum goal of $10,000 and a maximum goal of $1,070,000, and the proceeds will be used for hiring, manufacturing, and marketing. The product of Vymedic is patented, natural, and made up of amino acids, bioflavonoids, and co-factors. It is safe to use for children, elderly, pregnant women, and immunosuppressed individuals.
Investment Overview
Invested : $202,770
Deal Terms
Total Commitments
- Platform
- Netcapital
- Start Date
- 09/25/2020
- Close Date
- 03/24/2021
$10,000
$1,070,000
$100
Equity - Common
Early Stage
RegCF
/ RegD 506(c)
$5.00
$20,000,000
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2C
- Margin
- High
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 03/24/2021 | Netcapital | $20,000,000 | $202,770 | Equity - Common | Funded | RegCF / RegD 506(c) |
Founder Interview
Vymedic Founder Cynthia Winning on Antiviral Solutions
In the age of COVID-19, broad-spectrum, OTC, antivirals could change the game. Under the leadership of Cynthia Winning, the team at Vymedic is aiming to disrupt the OTC wellness space with a new immune support tablet. We sat down with Cynthia to discuss what inspired her to build the company, her vision for the future of the space, and more-